ABU DHABI – Insilico Medicine, a clinical-stage synthetic intelligence (AI)-driven drug discovery firm, at present introduced the opening of the Insilico Medicine Generative Synthetic Intelligence and Quantum Computing Research and Improvement Centre in Abu Dhabi, the area’s largest AI-powered biotechnology analysis centre.

Situated in the Worldwide Renewable Power Company (IRENA) headquarters in Masdar Metropolis, Abu Dhabi’s flagship sustainable city improvement, the analysis and improvement (R&D) hub will comprise international expertise in synthetic intelligence and software program improvement devoted to increasing the capabilities of Insilico’s end-to-end AI-driven drug discovery platform, Pharma.AI, exploring getting old analysis and sustainable chemistry, and supporting the digital transformation of healthcare in the area.

The grand opening occurred on the IRENA headquarters atrium in Masdar Metropolis, witnessed by almost 100 ecosystem companions from the federal government, academia, the funding neighborhood, and the AI and biotech trade. The occasion featured speeches from Omar bin Sultan Al Olama, Minister of State for Synthetic Intelligence, Digital Financial system, and Distant Work Functions, Alex Zhavoronkov, PhD, Founder and CEO of Insilico, and Alex Aliper, PhD, President of Insilico.

“The prime location, strong and stable economy, developed infrastructure, and highly educated talent make Abu Dhabi an emerging hub that attracts high-tech companies from around the world. We are excited to be a part of this,” mentioned the President of Insilico, who will function the regional hub’s basic supervisor. “We plan to hire locally and work closely with biotech companies and academic partners to license Insilico’s proprietary software and collaborate on joint research projects to facilitate the digital transformation of the local healthcare industry.”

“This is exactly the kind of groundbreaking work in artificial intelligence that we aim to support in our free zone and innovation ecosystem,” mentioned Ahmed Baghoum, Performing CEO of Masdar Metropolis. “We’re excited about this milestone for Insilico Medicine — particularly given it is taking place during the Year of Sustainability. We look forward to the transformational research that will come out of this incredible new hub. We thank the Abu Dhabi Investment Office for attracting these organisations to Masdar City.”

Insilico has made regular inroads into the Middle East. On thirty first January 2023, the corporate introduced that it’ll obtain assist from the Abu Dhabi Funding Workplace (ADIO) to determine its regional HQ in Abu Dhabi centered on R&D for its AI platform.

Abdulla Abdul Aziz AlShamsi, ADIO Performing Director-Basic, mentioned, “ADIO congratulates Insilico Medicine on opening a regional HQ in the UAE capital. Abu Dhabi has prioritised advancing technological solutions that further economic progress for the region and beyond. Insilico Medicine is a stellar example of the success of that strategy, and proof of the limitless opportunities available for health tech companies in Abu Dhabi.”

In August 2022, the corporate introduced a Collection D2 funding led by Prosperity7 Ventures, the diversified development fund of Aramco Ventures, increasing its AI biotechnology experience into Saudi Arabia. The corporate additionally signed a Memorandum of Understanding with the Ministry of Funding of Saudi Arabia, which incorporates offering Insilico’s end-to-end AI drug discovery platform to native biotech firms, partnering with native biotechs on robotic drug discovery, contributing to native medical trial experience, and additional growing initiatives extending wholesome and productive longevity.

Insilico founder and CEO Alex Zhavoronkov, PhD, was additionally a featured speaker on the World AI Summit in Riyadh, Saudi Arabia, in Sept. 2022, an occasion centered on AI for the great of humanity.

“Since our very inception, our mission has been to extend healthy, productive longevity for everyone on the planet. Over the past decade, we developed a platform for drug discovery and longevity and became one of the dominant companies in this field. Now, we would like to extend our global infrastructure to the Middle East,” mentioned Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine. “We look forward to expanding our presence and connections in the region by creating a true AI drug discovery hub in Abu Dhabi.”


What's Your Reaction?

hate hate
0
hate
confused confused
0
confused
fail fail
0
fail
fun fun
0
fun
geeky geeky
0
geeky
love love
0
love
lol lol
0
lol
omg omg
0
omg
win win
0
win
The Obsessed Guy
Hi, I'm The Obsessed Guy and I am passionate about artificial intelligence. I have spent years studying and working in the field, and I am fascinated by the potential of machine learning, deep learning, and natural language processing. I love exploring how these technologies are being used to solve real-world problems and am always eager to learn more. In my spare time, you can find me tinkering with neural networks and reading about the latest AI research.

0 Comments

Your email address will not be published. Required fields are marked *